Xtx Topco LTD Curis Inc Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.74 - $15.01 $63,836 - $1.29 Million	86,265 Added 56.3%	239,500 $168,000
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $92,006 - $314,893	129,586 Added 547.96%	153,235 $151,000
Q1 2022 May 13, 2022	SELL	$2.31 - $5.13 $29,355 - $65,192	-12,708 Reduced 34.95%	23,649 $56,000
Q4 2021 Feb 11, 2022	BUY	$4.45 - $8.09 $161,788 - $294,128	36,357 New	36,357 $173,000
Q3 2021 Nov 12, 2021	SELL	$6.94 - $8.85 $113,718 - $145,016	-16,386 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.45 - $16.27 $122,075 - $266,600	16,386 New	16,386 $132,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.